Project Details
Projekt Print View

CCL20 mediated onco-immuno-crosstalk in pancreatic cancer – translational intervention studies

Subject Area Gastroenterology
Term from 2018 to 2023
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 414216991
 
Final Report Year 2024

Final Report Abstract

The main objective of this project was a translational approach in murine and human in and ex vivo models to elaborate the clinical relevance of onco-immune-crosstalk in PDAC with an initial focus on the chemokine CCL20. We aimed to characterize the immune cells in detail using the simplified coculture model to further understand the mechanisms involved in the CCL20-mediated onco-immune-crosstalk. Hereby we were able to show that PDAC cells recruit immune cells through CCL20 and activate a TH17 response. We were able to show that the immune cells produce and secrete IL-17a and blocking IL-17 abolished the apoptosis protection through supernatants of PBMC. Finally, by using recombinant IL-17 we were able to mimic the PMBC supernatant-mediated protection of PDAC cells. Using an orthotropic syngeneic mouse model of PDAC with different CCL20 signaling competent and mutated settings in the mouse and/or the implanted PDAC cells we were able to confirm an in vivo relevance for therapy resistance of CCL20-mediated onco-immune crosstalk in murine PDAC. Finally, we tried to establish human organoid-coculture systems as a platform for translational therapy testing from EUS guided biopsies of human PDAC in combination with peripheral PBMC of the same patients.

Publications

 
 

Additional Information

Textvergrößerung und Kontrastanpassung